Faecal microbiota trasplant: Current status and perspectives beyond Clostridioides difficile infection

Affiliations

¹ Department of Microbiology, Hospital Universitario Ramón y Cajal and IRYCIS, Madrid, Spain; CIBERINFEC, Instituto de Salud Carlos III, Spain. Electronic address: rosa.campo@salud.madrid.org.
² CIBERINFEC, Instituto de Salud Carlos III, Spain; Department of Infectious Diseases, Hospital Universitario Ramón y Cajal and IRYCIS, Madrid, Spain.

Editorial

Rosa Del Campo et al. Enferm Infecc Microbiol Clin (Engl Ed). 2023 Apr.

. 2023 Apr;41(4):203-205.

doi: 10.1016/j.eimce.2022.10.011. Epub 2023 Feb 1.

¹ Department of Microbiology, Hospital Universitario Ramón y Cajal and IRYCIS, Madrid, Spain; CIBERINFEC, Instituto de Salud Carlos III, Spain. Electronic address: rosa.campo@salud.madrid.org.
² CIBERINFEC, Instituto de Salud Carlos III, Spain; Department of Infectious Diseases, Hospital Universitario Ramón y Cajal and IRYCIS, Madrid, Spain.

No abstract available

Comment on

Faecal Microbiota Transplantation is a simple, effective and safe treatment in the management of C. difficile infection in daily clinical practice.
Ferre Aracil C, El Hajra Martínez I, Vera Mendoza MS, Ramos Martínez A, Muñez Rubio E, Fernández-Cruz A, Matallana Royo V, García-Maseda S, Sánchez Romero I, Martínez Ruiz R, Calleja Panero JL. Ferre Aracil C, et al. Enferm Infecc Microbiol Clin (Engl Ed). 2023 Apr;41(4):206-210. doi: 10.1016/j.eimce.2022.01.004. Epub 2023 Jan 19. Enferm Infecc Microbiol Clin (Engl Ed). 2023. PMID: 36681571